To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses

NCT01469923 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: AZD2820
DRUG: Placebo

Sponsor

AstraZeneca